The results suggest upregulation of these EMT markers and suggests that in these PCa cell lines LYL1 negatively regulates both epithelial (CDH1) and mesenchymal markers (CDH2) with no significant effects for vimentin as mesenchymal marker (figure S5). The gene discussed is VIM; the disease is posterior cortical atrophy.